ClinicalTrials.gg
Not yet recruitingNCT07947628Updated Nov 19, 2026

Effects of Two Fresh Gas Flow Rates During Anesthesia for Lumbar Stabilization Surgery

An interventional study of Minimal Fresh Gas Flow at 0.3 L/min and Fresh Gas Flow at 2 L/min in Respiratory Mechanics, Carbon Footprint and Low-Flow Anesthesia, sponsored by Hande Gurbuz. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-19.

Sponsored by Hande Gurbuz · Not applicable, Interventional, and Basic science

How we know

Updated Nov 19, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
86
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-19

Among 144 studies in Postoperative Complications with a site in Turkey — 33 open to participants now, 40 under way, none of them phase 3. Postoperative Complications · Turkey.

Planned enrollment
30th of 67
86 · median 80
Started
2026
with 20 others
No phase
59 of 144
12 open now
Primary completion
2027-12
later than 37 of 39 live
Registered
144th of 144
by date

Among the 144 studies in Postoperative Complications with a site in Turkey, this one is the 30th largest by planned enrollment of the 67 interventional ones that give a count, is one of 21 that started in 2026, is one of 59 with no phase, reaches primary completion later than 37 of the 39 other live ones, and was the 144th registered.

Postoperative Complications

1,338 studies on the registry are indexed under Postoperative Complications; 311 are open to participants now.

Browse Postoperative Complications studies →

Open to participants now

33 of the 144 studies in Postoperative Complications with a site in Turkey are open now. Recruiting first, the newest first:

28 more — sign in →

All 33 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 201 Postoperative Complications studies recruiting now, 126 (63%) set no upper age limit and 32 (16%) stop at 75 or younger; 24 take children under 18; 25 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 144 studies in Postoperative Complications with a site in Turkey, or all of them as a file.
02

Study summary

This study will compare two fresh gas flow rates during general anesthesia in adults undergoing lumbar stabilization surgery while lying face down. Fresh gas flow is the rate at which oxygen and other gases are supplied to the anesthesia breathing system. Lower flow rates may reduce anesthetic use and its environmental impact, but their effects on breathing during prolonged surgery need further evaluation.

Seventy adults will be randomly assigned to receive a fresh gas flow rate of either 0.3 or 2 liters per minute. Both groups will receive sevoflurane anesthesia and standardized mechanical ventilation.

The main outcome is the percentage change in dynamic respiratory system compliance, a measure of how easily the lungs and chest expand during ventilation, between 10 and 120 minutes after reaching the assigned flow rate. Other assessments will include breathing mechanics, blood oxygen and carbon dioxide levels, brain oxygenation, lung ultrasound findings, postoperative oxygen needs, pulmonary complications, and hospital length of stay. Anesthetic and fresh gas consumption, anesthetic cost, and estimated greenhouse gas emissions will also be compared. Fresh gas flow will be increased if predefined safety criteria are met.

Read the detailed description

This single-center trial will be conducted at Bursa City Hospital. Adults aged 18 years or older who are scheduled for elective lumbar stabilization surgery in the prone position will be enrolled. Eligible participants will have an American Society of Anesthesiologists physical status classification of I-III, a body mass index below 40 kg/m², and no known pulmonary disease. Written informed consent will be obtained before enrollment. Participants will be assigned by computer-generated randomization to two parallel groups: minimal fresh gas flow at 0.3 L/min or comparator fresh gas flow at 2 L/min.

Before anesthesia induction, demographic characteristics, comorbidities, smoking status, and hemoglobin levels will be recorded. Lung ultrasound will assess 12 zones, with each zone scored from 0 to 3, yielding a total score of 0-36. Higher scores indicate greater loss of lung aeration.

Automated controlled anesthesia will be used to target an end-tidal sevoflurane concentration corresponding to approximately 1 minimum alveolar concentration, with a bispectral index target of 40-60. Volume-controlled ventilation will be standardized.

High fresh gas flow will initially be used after induction and tracheal intubation. After prone positioning and confirmation of hemodynamic and ventilatory stability, the assigned fresh gas flow rate will be applied. Measurements will be obtained at the following time points:

T1: 5-10 minutes after intubation, while supine during the initial high-flow period.

T2: 10 minutes after reaching the assigned fresh gas flow rate in the prone position.

T3: 30 minutes after reaching the assigned flow rate. T4: 60 minutes after reaching the assigned flow rate. T5: 120 minutes after reaching the assigned flow rate.

Respiratory mechanics, hemodynamic variables, cerebral oxygenation, and arterial blood gas measurements will be recorded at the specified intraoperative time points. Dynamic compliance will be calculated as expired tidal volume divided by the difference between peak inspiratory pressure and positive end-expiratory pressure. Its percentage change will be calculated as [(T5 value - T2 value) / T2 value] × 100. Plateau pressure will be measured using an inspiratory hold. Static compliance, driving pressure, airway resistance, elastance, and mechanical power will also be evaluated. Pulmonary gas exchange assessments will include the PaO2/FiO2 ratio, the alveolar-arterial oxygen gradient, and the arterial-to-end-tidal carbon dioxide difference.

At 30 minutes after surgery in the postanesthesia care unit, lung ultrasound, peripheral oxygen saturation, supplemental oxygen requirements, pain, and early pulmonary complications will be assessed. The change in lung ultrasound score will be calculated as the postoperative score minus the preoperative score. Pulmonary complications during hospitalization and hospital length of stay will also be recorded.

Total sevoflurane and fresh gas consumption will be obtained from the anesthesia workstation. Sevoflurane cost will be calculated using the consumed volume and the unit price determined at the end of the study. Estimated sevoflurane-related carbon dioxide equivalent emissions will be calculated using the protocol-specified conversion factor of approximately 0.198 kg CO2e per milliliter of sevoflurane.

03

Conditions studied

  • Respiratory Mechanics
  • Carbon Footprint
  • Low-Flow Anesthesia
  • Ultrasonography
  • Postoperative Complications
  • Lung Compliance

Keywords

  • Lung Ultrasound
  • Low-Flow Anesthesia
  • Minimal-Flow Anesthesia
  • Dynamic Compliance
  • Prone Position
  • Lumbar Stabilization Surgery
  • Postoperative Pulmonary Complications
  • Carbon Footprint
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 years or older.
  • Scheduled for elective lumbar stabilization surgery in the prone position.
  • (ASA) physical status I-III.
  • below 40 kg/m².
  • No known pulmonary disease.
  • Willing and able to provide written .

Exclusion criteria

Exclusion Criteria:

  • IV or higher.
  • of 40 kg/m² or higher.
  • Known pulmonary disease.
  • Declining to participate or not providing written .
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
86 participants (estimated)

Study arms

  • Experimental
    Minimal Fresh Gas Flow (0.3 L/min)

    Participants will receive a fresh gas flow rate of 0.3 L/min during sevoflurane anesthesia after prone positioning and confirmation of hemodynamic and ventilatory stability. Mechanical ventilation will follow the standardized study protocol. High fresh gas flow will be used if predefined rescue criteria are met.

    Other: Minimal Fresh Gas Flow at 0.3 L/min

  • Active comparator
    Fresh Gas Flow (2 L/min)

    Participants will receive a fresh gas flow rate of 2 L/min during sevoflurane anesthesia after prone positioning and confirmation of hemodynamic and ventilatory stability. Mechanical ventilation will follow the standardized study protocol. High fresh gas flow will be used if predefined rescue criteria are met.

    Other: Fresh Gas Flow at 2 L/min

Interventions

  • OtherMinimal Fresh Gas Flow at 0.3 L/min

    Fresh gas flow will be reduced to 0.3 L/min after prone positioning and confirmation of hemodynamic and ventilatory stability. Sevoflurane will be administered using automated controlled anesthesia to target approximately 1 minimum alveolar concentration. The assigned flow will be maintained unless predefined rescue criteria require an increase in fresh gas flow.

  • OtherFresh Gas Flow at 2 L/min

    Fresh gas flow will be set at 2 L/min after prone positioning and confirmation of hemodynamic and ventilatory stability. Sevoflurane will be administered using automated controlled anesthesia to target approximately 1 minimum alveolar concentration. The assigned flow will be maintained unless predefined rescue criteria require an increase in fresh gas flow.

06

What researchers measure

Primary outcomes

  1. Percentage Change in Dynamic Respiratory System Compliance

    Dynamic respiratory system compliance (Cdyn), expressed in mL/cmH2O, will be recorded directly from the anesthesia workstation. The percentage change will be calculated as \[(Cdyn at T5 - Cdyn at T2) / Cdyn at T2\] × 100. T2 is 10 minutes and T5 is 120 minutes after reaching the assigned fresh gas flow rate in the prone position. Negative values indicate a decrease in compliance; higher values indicate better preservation of compliance.

    Time frame: From 10 to 120 minutes after reaching the assigned fresh gas flow rate in the prone position during surgery.

Secondary outcomes

  1. Change in Static Respiratory System Compliance

    Static respiratory system compliance (Cstat) will be calculated as expired tidal volume divided by plateau pressure minus positive end-expiratory pressure and expressed in mL/cmH2O. Plateau pressure will be measured during a 2-second inspiratory hold. The change will be calculated as Cstat at T5 minus Cstat at T2. Negative values indicate a decrease in compliance.

    Time frame: From 10 to 120 minutes after reaching the assigned fresh gas flow rate in the prone position during surgery.

  2. Change in Driving Pressure

    Driving pressure will be calculated as plateau pressure minus positive end-expiratory pressure and expressed in cmH2O. Plateau pressure will be measured during a 2-second inspiratory hold. The change will be calculated as driving pressure at T5 minus driving pressure at T2. Positive values indicate an increase in driving pressure.

    Time frame: From 10 to 120 minutes after reaching the assigned fresh gas flow rate in the prone position during surgery.

  3. Change in Airway Resistance

    Airway resistance will be recorded directly from the anesthesia workstation and expressed in cmH2O·s/L. The change will be calculated as airway resistance at T5 minus airway resistance at T2. Positive values indicate an increase in airway resistance.

    Time frame: From 10 to 120 minutes after reaching the assigned fresh gas flow rate in the prone position during surgery.

  4. Change in Mechanical Power

    Mechanical power during volume-controlled ventilation will be calculated as: 0.098 × tidal volume (L) × respiratory rate (breaths/min) × \[peak inspiratory pressure - 0.5 × (plateau pressure - positive end-expiratory pressure)\]. Pressures will be expressed in cmH2O and mechanical power in J/min. The change will be calculated as mechanical power at T5 minus mechanical power at T2. Positive values indicate an increase in mechanical power.

    Time frame: From 10 to 120 minutes after reaching the assigned fresh gas flow rate in the prone position during surgery.

  5. Change in Respiratory System Elastance

    Respiratory system elastance will be recorded directly from the anesthesia workstation. The change will be calculated as elastance at T5 minus elastance at T2. Positive values indicate increased respiratory system stiffness.

    Time frame: From 10 to 120 minutes after reaching the assigned fresh gas flow rate in the prone position during surgery.

  6. Change in PaO2/FiO2 Ratio

    The PaO2/FiO2 ratio will be calculated by dividing arterial oxygen partial pressure (PaO2, in mmHg) by the simultaneously recorded inspired oxygen fraction (FiO2, expressed as a decimal). The change will be calculated as the ratio at T5 minus the ratio at T2 and expressed in mmHg. Positive values indicate improved oxygenation.

    Time frame: From 10 to 120 minutes after reaching the assigned fresh gas flow rate in the prone position during surgery.

  7. Total Sevoflurane Consumption

    Total liquid sevoflurane consumption during anesthesia will be recorded directly from the anesthesia workstation and expressed in milliliters.

    Time frame: From the start of anesthesia to the end of anesthesia on the day of surgery.

  8. Estimated Sevoflurane-Related Carbon Dioxide Equivalent Emissions

    Estimated carbon dioxide equivalent (CO2e) emissions associated with sevoflurane consumption will be calculated by multiplying the total liquid sevoflurane volume consumed during anesthesia by the protocol-specified conversion factor of 0.198 kg CO2e per milliliter. Results will be expressed in kilograms of CO2e. This estimate covers sevoflurane-related emissions rather than the total carbon footprint of anesthesia or surgery.

    Time frame: From the start of anesthesia to the end of anesthesia on the day of surgery.

  9. Change in Lung Ultrasound Score

    Lung aeration will be assessed using a 12-zone lung ultrasound examination. Each zone will be scored from 0 to 3, yielding a total score of 0-36, with higher scores indicating greater loss of aeration. The change will be calculated as the postoperative score minus the preoperative score. Positive values indicate worsening lung aeration.

    Time frame: From before anesthesia induction to 30 minutes after surgery in the postanesthesia care unit.

  10. Incidence of Postoperative Pulmonary Complications

    The proportion of participants experiencing at least one postoperative pulmonary complication during hospitalization will be compared between groups. Complications will include atelectasis, pneumonia, respiratory failure, bronchospasm, aspiration pneumonitis, pleural effusion, and pneumothorax. Each participant will be counted once for the overall incidence, regardless of the number of complications. The type of each complication will also be recorded.

    Time frame: Postoperative hospitalization, an average of 10 days.

07

Study locations

1 site
08

References and documents

Publications

  • Prasad TK, Gnanasekar N, Priyadharsini KS, Chacko RS. Randomized double-blind trial comparing effects of low-flow vs high-flow anesthesia on postoperative lung functions using respirometer. J Anaesthesiol Clin Pharmacol. 2020 Oct-Dec;36(4):535-540. doi: 10.4103/joacp.JOACP_410_19. Epub 2021 Jan 18. PubMed 33840937 ↗
  • Gattinoni L, Tonetti T, Cressoni M, Cadringher P, Herrmann P, Moerer O, Protti A, Gotti M, Chiurazzi C, Carlesso E, Chiumello D, Quintel M. Ventilator-related causes of lung injury: the mechanical power. Intensive Care Med. 2016 Oct;42(10):1567-1575. doi: 10.1007/s00134-016-4505-2. Epub 2016 Sep 12. PubMed 27620287 ↗
  • Aydin BS, Acikgoz E. Effect of the prone position on mechanical power in elective surgical patients under general anesthesia: A prospective observational study. Saudi Med J. 2024 Aug;45(8):814-820. doi: 10.15537/smj.2024.45.8.20240242. PubMed 39074888 ↗
  • Celik EC, Yayik AM, Aydin ME, Koksal ENM, Disci E, Kerget B, Doymus O, Ahiskalioglu EO, Ahiskalioglu A. Evaluation of lung dynamics and respiratory functions in patients undergoing minimal flow anesthesia: a prospective, randomized controlled trial. Med Gas Res. 2026 Jun 1;16(2):110-115. doi: 10.4103/mgr.MEDGASRES-D-25-00037. Epub 2025 Aug 18. PubMed 40826933 ↗

Individual participant data

Plan to share: No — There is no plan to share individual participant data with other researchers. Study findings will be reported in aggregate form.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Dec 2027, 13 months later.

Of 395 non-industry interventional studies with no phase under Postoperative Complications, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 44. This study's planned 13 months is below that.

Counting every sponsor, half of 399 studies reached it within 20 months; a quarter within 8 and three quarters within 44.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 12, 2026
First posted
Nov 19, 2026
StartEst.
Nov 2026
Primary completionEst.
Dec 2027
CompletionEst.
Dec 2027
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 19, 2026
Show all 1 update
  1. Nov 19, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07947628
Lead sponsor
Hande Gurbuz
Responsible party
Hande Gurbuz (Professor of Anesthesiology and Reanimation, Bursa City Hospital) — Sponsor-investigator
First posted
Nov 19, 2026
Start date
Nov 2026 (estimated)
Primary completion
Dec 2027 (estimated)
Completion
Dec 2027 (estimated)
Last update
Nov 19, 2026

Study contacts

Hande Gurbuz, Prof, MD, PhD
Contact
handegrbz@gmail.com
+90 533 651 56 50
Esma Busra Ergin, MD
Contact
esmabusragun@gmail.com
+90 543 936 56 01
Hande Gurbuz, Prof, MD, PhD
principal investigator · University of Health Sciences, Bursa School of Medicine, Bursa City Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion